Former FDA commissioners recently gathered at the Aspen Ideas Festival’s Spotlight Health discussing ways to minimize bureaucratic and political red tape. FDA’s science based recommendations of safety and efficacy of food and drugs many times have political pressures and challenges to overcome. Former regulation executives coming together to share and leveraging their many years of experience may ultimately produce a positive change. Perhaps there could be a better path forward than the current system we have in place? Check out Sy Mukherjee’s informative article on Fortune.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.